The European School Oncology (ESO) will host a free e-learning session with experts in the field entitled, “Precision medicine in cancer- where are we?” Fabrice André, MD, PhD is the expert presenter.
Precision Medicine has gotten so big that analysts expect the market to skyrocket past $87 billion worldwide by 2023. As more healthcare organizations nationwide put precision medicine into practice, the opportunities it brings for disease treatment and prevention are enormous. But the challenges are also very real.
The HIMSS Precision Medicine Summit provides attendees with the insights and tools they need to address those challenges head on – and take the next steps. Join us for 2 full days of case studies, best practices, panel discussions, and unrivaled networking opportunities.
What you’ll get:
- Dip deeper than ever into precision medicine barriers with 2 full days of expert keynotes, panels and breakout sessions
- Learn emerging technologies, the latest trends, and success strategies around personal genomics, diagnostics, immunotherapy, analytics, infrastructure and more
- Network with peers, thought leaders, and precision medicine experts, and get the insights you need to move forward
European Alliance for Personalized Medicine (EAPM) 2017 Congress
In response to the need for a wider understanding of the priorities arising from growing discussion on personalized medicine, the European Alliance for Personalized Medicine (EAPM) was launched in March 2012 to foster a more integrated approach to the topic among lay and professional stakeholders.
The EAPM brings together European healthcare experts, patient advocates involved with chronic diseases, industry, researchers, academics and cross-party Members of the European Parliament (among others). Its aim is to improve patient care by accelerating the development, delivery and uptake of personalized medicine and diagnostics, through consensus building.
The 2017 Congress “Personalizing Your Health: A Global Imperative” will be the first ever pan-European, multidisciplinary Congress specific to the fast-moving field of personalized medicine and will feature cancer-specific streams and symposia under the banner of “Cancer: A paradigm for personalized health.” The high-level gathering will act as a one-stop-shop for multi-stakeholders and provide the biggest ‘space’ to date to allow for such a meeting of minds and expertise, top-level discussion and the formulation of real action plans.